IGC Pharma (IGC) Short term Debt (2011 - 2026)
IGC Pharma (IGC) reported Short term Debt of $27000.0 for Q1 2026, down 85.0% quarter-over-quarter from $180000.0 in Q4 2025.
IGC Pharma (IGC) Short term Debt (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has 11 years of Short term Debt data on file, last reported at $27000.0 in Q1 2026.
- Short term Debt for Q1 2026 came in at $27000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $27000.0 (changed N/A YoY), and the FY2026 annual result was $27000.0, changed N/A from the prior year.
- Short term Debt slipped to $27000.0 in Q1 2026 per IGC's latest filing, from $180000.0 in the prior quarter.
- Over five years, Short term Debt peaked at $180000.0 in Q4 2025 and troughed at $3000.0 in Q1 2022.
- A 3-year average of $53250.0 and a median of $15000.0 in 2022 frame the typical range for Short term Debt.
- On a YoY basis, Short term Debt climbed as much as 0.0% in 2022 and fell as far as 99.01% in 2022.
- A 3-year view of Short term Debt shows it stood at $3000.0 in 2022, then surged by 5900.0% to $180000.0 in 2025, then tumbled by 85.0% to $27000.0 in 2026.
- Business Quant data shows IGC's Short term Debt at $27000.0 in Q1 2026, $180000.0 in Q4 2025, and $3000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 304,000.00 |
| Dec 31, 2020 | 252,000.00 |
| Sep 30, 2020 | 196,000.00 |
| Mar 31, 2020 | 50,000.00 |
| Dec 31, 2019 | 50,000.00 |
| Sep 30, 2019 | 50,000.00 |
| Jun 30, 2019 | 50,000.00 |
| Mar 31, 2019 | 50,000.00 |
| Jun 30, 2016 | 12,591.00 |
| Mar 31, 2016 | 27,762.00 |
| Dec 31, 2015 | 538,432.00 |
| Sep 30, 2015 | 510,909.00 |
| Jun 30, 2015 | 1.28 Mn |